Literature DB >> 19157508

Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.

Hyo Sup Shim1, Bo Sung Yoon, Nam Hoon Cho.   

Abstract

This study was designed to investigate the prognostic significance of the expression of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. The expression of epithelial cell adhesion molecule and E-cadherin was examined immunohistochemically on a tissue microarray of formalin-fixed paraffin-embedded tissue specimens from 72 consecutive patients. The overexpression of epithelial cell adhesion molecule was correlated with poor survival (P = .036). In contrast, the reduced expression of E-cadherin was correlated with poor survival (P = .034). When patients were subclassified into 4 groups according to positivity and negativity of epithelial cell adhesion molecule and E-cadherin expression, the epithelial cell adhesion molecule-positive E-cadherin-negative group showed the worst survival rate (P = .002, compared with the epithelial cell adhesion molecule-negative E-cadherin-positive group). These data suggest that the overexpression of epithelial cell adhesion molecule and reduced expression of E-cadherin in combination is more significant than a single marker for predicting poor survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157508     DOI: 10.1016/j.humpath.2008.10.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Authors:  Geoffrey Kim; Ben Davidson; Ryan Henning; Junbai Wang; Minshu Yu; Christina Annunziata; Thea Hetland; Elise C Kohn
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma.

Authors:  Takahito Miyake; Yutaka Ueda; Shinya Matsuzaki; Takashi Miyatake; Kiyoshi Yoshino; Masami Fujita; Taisei Nomura; Takayuki Enomoto; Tadashi Kimura
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-23       Impact factor: 4.553

3.  Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas.

Authors:  Kristi Ward; Clarissa Amaya; Kundan Verma; Dat Tran; Dolores Diaz; Alireza Torabi; Brad A Bryan
Journal:  Mol Clin Oncol       Date:  2014-09-25

4.  Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients.

Authors:  Marco Johannes Battista; Cristina Cotarelo; Sina Jakobi; Joscha Steetskamp; Georgios Makris; Isabel Sicking; Veronika Weyer; Marcus Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-13       Impact factor: 4.553

5.  Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.

Authors:  Branka Petrić Miše; Vesna Dobrić Telesmanić; Snježana Tomić; Dinka Šundov; Vesna Čapkun; Eduard Vrdoljak
Journal:  Pathol Oncol Res       Date:  2014-08-11       Impact factor: 3.201

6.  Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer.

Authors:  Faruk Tas; Senem Karabulut; Murat Serilmez; Rumeysa Ciftci; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2013-12-04

7.  Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor.

Authors:  Jae-Heon Jeong; Byoung Chul Cho; Hyo Sup Shim; Hye-Ryun Kim; Sun-Min Lim; Se Kyu Kim; Kyung Young Chung; S M Bakhtiar Ul Islam; Jae Jin Song; Soo-Youl Kim; Joo Hang Kim
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

8.  The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer.

Authors:  Shingo Tayama; Takeshi Motohara; Dashdemberel Narantuya; Chenyan Li; Koichi Fujimoto; Isao Sakaguchi; Hironori Tashiro; Hideyuki Saya; Osamu Nagano; Hidetaka Katabuchi
Journal:  Oncotarget       Date:  2017-07-04

9.  Fluid biopsy for circulating tumor cells in an occult ovarian cancer patient exhibiting bilateral supraclavicular lymph node metastases: A case report.

Authors:  Shizhi He; Pingdong Li; Xiaohong Chen; Zhenkun Yu
Journal:  Oncol Lett       Date:  2013-05-24       Impact factor: 2.967

10.  Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.

Authors:  Cécile Le Page; David G Huntsman; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.